Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study

被引：0
|
作者：
Ya-Nan Jin
Zhao-Hui Ruan
Wan-Wei Cao
Lin Yang
Wei Yao
Xiao-Feng Pei
Wang-Jian Zhang
Tia Marks
Ji-Jin Yao
Liang-Ping Xia
机构：
[1] Sun Yat-Sen University Cancer Center,VIP Region, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Collaborative Innovation Center for Cancer Medicine
[2] The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Pathology
[3] The Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Radiation Oncology
[4] Nanfang Hospital,Department of Medical Statistics, School of Public Health
[5] Southern Medical University,Department of Environmental Health Sciences, School of Public Health
[6] Sun Yat-Sen University,undefined
[7] University at Albany,undefined
[8] State University of New York,undefined
[9] Guangdong Provincial Key Laboratory of Biomedical Imaging,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Nasopharyngeal carcinoma; Propensity score matching; Neoadjuvant chemotherapy; Concurrent chemoradiotherapy; Children and adolescents;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11929 / 11940
页数：11
相关论文
共 50 条
  • [1] Concurrent chemoradiotherapy with or without neoadjuvant chemotherapy in pediatric patients with stage III-IVa nasopharyngeal carcinoma: a real-world propensity score-matched cohort study
    Jin, Ya-Nan
    Ruan, Zhao-Hui
    Cao, Wan-Wei
    Yang, Lin
    Yao, Wei
    Pei, Xiao-Feng
    Zhang, Wang-Jian
    Marks, Tia
    Yao, Ji-Jin
    Xia, Liang-Ping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (13) : 11929 - 11940
  • [2] Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities
    Jin, Ya-Nan
    Xiao, Zhi-Wen
    Yao, Wei
    Yu, Jing
    Zhang, Wang-Jian
    Marks, Tia
    Zhang, Hong-Yu
    Yao, Ji-Jin
    Xia, Liang-Ping
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (08): : 2020 - 2030
  • [3] Gemcitabine and cisplatin induction chemotherapy followed by concurrent chemoradiotherapy for stage III-IVA nasopharyngeal carcinoma: A real-world study
    Van, Dang Nguyen
    Viet, Son Nguyen
    Phu, Gia Hoang
    SCIENCE PROGRESS, 2025, 108 (01)
  • [4] A real-world study: Induction chemoimmunotherapy versus induction chemotherapy followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma patients with stage IVa
    Wu, K.
    Li, Q.
    Luo, X.
    Wei, X.
    Wang, L.
    Li, Y. -S.
    ANNALS OF ONCOLOGY, 2024, 35
  • [5] Concurrent chemoradiotherapy combined with nimotuzumab in stage III-IVa nasopharyngeal carcinoma: a retrospective analysis
    Cai, Zhuochen
    Chen, Dongni
    Qiu, Wenze
    Liang, Chixiong
    Huang, Yingying
    Zhou, Jiayu
    Zhan, Zejiang
    Xiang, Yanqun
    Guo, Xiang
    Lv, Xing
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2327 - 2344
  • [6] Individualized Concurrent Chemotherapy for Patients with Stage III-IVa Nasopharyngeal Carcinoma Receiving Neoadjuvant Chemotherapy Combined with Definitive Intensity-Modulated Radiotherapy
    Ji, Pengjie
    Lu, Qiongjiao
    Chen, Xiaoqiang
    Chen, Yuebing
    Peng, Xiane
    Chen, Zhiwei
    Lin, Cheng
    Lin, Shaojun
    Zong, Jingfeng
    CANCER RESEARCH AND TREATMENT, 2023, 55 (04): : 1113 - 1122
  • [7] Evaluation of Adjuvant Chemotherapy after Induction Chemotherapy and Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Patients: A Propensity Score-Matched Analysis
    He, Y.
    Li, Y.
    Tang, Q.
    Ma, S.
    Xiong, Z.
    Huang, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E758 - E758
  • [8] Transarterial chemoembolization with or without sorafenib for hepatocellular carcinoma: A real-world propensity score-matched study
    Peng, Tzu-Rong
    Wu, Ta-Wei
    Wu, Chao-Chuan
    Chang, Sou-Yi
    Chan, Cheng-Yi
    Hsu, Ching-Sheng
    TZU CHI MEDICAL JOURNAL, 2022, 34 (02): : 219 - 225
  • [9] Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A propensity score-matched analysis
    Tang, Si-Qi
    Xu, Cheng
    Wang, Xiao-Shuai
    Tang, Ling-Long
    Li, Wen-Fei
    Chen, Lei
    Mao, Yan-Ping
    Guo, Rui
    Liu, Qing
    Sun, Ying
    Ma, Jun
    ORAL ONCOLOGY, 2020, 105
  • [10] Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study
    Wang, Fang
    Zhou, Lu
    Zhang, Li-Jun
    Xie, Chang-Bin
    Liao, Zhi-Wei
    Lin, Xiao-Dan
    Wen, Yue- Feng
    RADIOTHERAPY AND ONCOLOGY, 2024, 191
12345